drugset / Press release
Scandion Oncology receives approvals for next parts of the CORIST trial
2022-08-19 · Scandion Oncology A/S · original scandiononcology.com ↗
The development of SCO-101 will continue as planned with expansion of the CORIST trial expected to commence during the third quarter of 2022.
The release as fetched from its publisher. scandiononcology.com ↗